Fundamental study of neuronal cell differentiation system by transfection with glial fibrillary acidic protein gene.
Fundamental study of neuronal cell differentiation system by transfection with glial fibrillary acidic protein gene.
批准号:
04670859
负责人:
WAKABAYASHI Toshihiko
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
胶质纤维酸性蛋白(GFAP)是在成熟的正常星形胶质细胞和分化的胶质瘤细胞中发现的一种中间丝,它似乎与微丝、微管等其他细胞骨架成分一起稳定星形胶质细胞的细胞骨架,帮助维持星形胶质细胞的形态,但其组织特异性作用尚不清楚。通过脂质体将GFAP基因导入不表达GFAP的人髓母细胞瘤细胞系(DAOY-1),以验证GAFP在脑瘤细胞中的表达效果。转染后,我们研究了GFAP转染组细胞的生物学特性变化。比较GFAP转染组与未转染组的细胞生长、细胞形态及对细胞因子或抗癌药物的敏感性。结果表明,GFAP基因转染的细胞1)生长抑制,2)对某些抗癌药物如ACNU和顺铂的敏感性增加,3)高表达肿瘤相关细胞表面抗原,如已知的细胞间黏附分子之一G-22,4)形态变化不明显。这些结果提示GFAP基因转导细胞对抗癌药物具有更高的敏感性,有望在脑肿瘤的治疗中得到临床应用。
英文摘要
Glial fibrillary acidic protein (GFAP) is one of the intermediate filaments which was found in mature normal astrocytes and differentiated glioma cells It seems to stabilize the astrocyte's cytoskeleton and help maintain astrocyte cell shape together with other cytoskeletal components such as microfilament and microtubule, however its tissue-specific role is not clear. To verify the effect of GAFP expression in brain tumor cell, transfer of GFAP gene into human medulloblastoma cell line (DAOY-1) which dose not express GFAP was performed by means of liposomes. After tranfection, we studied the alteration of chracteristics in GFAP transfected cells. Cell growth, morphology and sensitivity of cytokine or anticancer drugs were compared between GFAP transfected and non-transfected cells. As a result, the GFAP gene transfected cells demonstrated that, 1) Growth inhibition, 2) Increase of sensitivity to some anticancer drugs such as ACNU and Cisplatinum, 3) High expression of tumor related cell surface antigen such as G-22, which is known as one of the intercellular adhesion molecule, 4) although morphological changes was not apparent. These results suggest that GFAP gene transfected cell has a possibility to be more sensitive for the anticancer drugs, and it is expected the clinical application for the treatment of malignant brain tumors.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
吉田純: "経過観察中急速な腫瘍増大を示したSubepmdymol Giant Cell Astrorytanaの一例" 厚生省特定疾患、神経皮膚症候群調査研究班、平成4年度研究報告書. 28-30 (1993)
Jun Yoshida:“在随访期间显示肿瘤快速生长的 Subepmdymol 巨细胞 Astrorytana 病例”厚生省特定疾病,神经皮肤综合症调查研究组,1992 年研究报告 28-30 (1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
若林俊彦: "悪性脳腫瘍に対する遺伝子療法" 名古屋医報. 1019. 11-13 (1993)
Toshihiko Wakabayashi:“恶性脑肿瘤的基因治疗”名古屋医学杂志。1019. 11-13 (1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
吉田純: "Glial fibrillary acidic protein(GFAP)遺伝子導入による脳腫瘍細胞の増殖に及ぼす影響" 厚生省特定疾患.神経皮フ症候群調査研究班.平成4年度研究報告書. 27-28 (1993)
Jun Yoshida:“神经胶质纤维酸性蛋白(GFAP)基因导入对脑肿瘤细胞生长的影响”厚生省特定疾病研究小组1992年研究报告。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
吉田純: "経過観察中急速な腫瘍増大を示したSubependymal Giant Cell Astrocytemaの一例." 厚生省特定疾患.神経皮フ症候群調査研究班.平成4年度研究報告書. 28-30 (1993)
Jun Yoshida:“室管膜下巨细胞星形胶质细胞瘤在随访期间显示肿瘤快速生长。”卫生和福利部神经皮肤 F 综合征研究小组 1992 年研究报告。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Wakabayashi, J.Yoshida: "Gene therapy for malignant brain tumor" Nagoya-Ihoh. vol 1019. 11-13 (1993)
T.Wakabayashi、J.Yoshida:“恶性脑肿瘤的基因治疗”Nagoya-Ihoh。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
Development of molecular imaging tracers for anticancer drug resistant proteins
-
批准号:21390409
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.57万
-
财政年份:2009
-
负责人:WAKABAYASHI Toshihiko
-
依托单位:
Clinical evaluation of efficacy and safety of dendritic cell-based vaccine therapy using with HLA-A2 restricted IL-13 alpha receptor peptide in patients with malignant glioma managed by international organization for standardization
-
批准号:18390395
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.98万
-
财政年份:2006
-
负责人:WAKABAYASHI Toshihiko
-
依托单位:
Effective induction of antiglioma cytotoxic T cells by coadministration of heat-induction antigen by means of bio-nanoparticles dendritic cells
-
批准号:16390409
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2004
-
负责人:WAKABAYASHI Toshihiko
-
依托单位:
Induction of anti-tumor immunity by intracellular hyperthermia using magnetite
-
批准号:14370430
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.32万
-
财政年份:2002
-
负责人:WAKABAYASHI Toshihiko
-
依托单位:
Antitumor activity by intracellular hyperthermia using magnetite
-
批准号:11671365
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1999
-
负责人:WAKABAYASHI Toshihiko
-
依托单位:
Specific Imaging and Intracellular Hyperthermia for Brain Tumor using Magnetite Particle conjugated with monoclonal antibody
-
批准号:08671574
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:WAKABAYASHI Toshihiko
-
依托单位:
Tenascin in cerebrospinal fluid is a useful biomarker for the diagosis of brain tumor
-
批准号:06671383
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:WAKABAYASHI Toshihiko
-
依托单位:
海外基金